Literature DB >> 28685199

Pacemaker-induced tricuspid regurgitation is uncommon immediately post-implantation.

Daniel P Rothschild1, James A Goldstein1,2, Nathan Kerner1,2, Amr E Abbas1,2, Meet Patel1, Wai Shun Wong3,4.   

Abstract

BACKGROUND: Prior studies report permanent pacemaker (PPM)-induced tricuspid regurgitation (TR) in up to one third of cases late post-implantation. We sought to assess the extent of immediate PPM-induced TR.
METHODS: Forty patients undergoing PPM implant were prospectively enrolled. Patients with pre-existing moderate or severe TR or an RVSP >50 mmHg were excluded. Pre- and immediate post-implantation transthoracic echocardiography (TTE) analyzed TR grade according to established methods. 3D TTE was utilized to determine lead position in relation to tricuspid leaflets as well as lead mobility across the TV.
RESULTS: Of 40 patients, four were excluded due to baseline moderate TR (n = 3) or RVSP >50 mmHg (n = 1). In the remaining cohort (n = 36), immediate post-implantation TTE showed no increase in TR grade in 30 patients (83%), whereas a one-grade increase from no/trace to mild occurred in six (17%) others. In no patient did immediate moderate or severe TR develop. Exclusive RV pacing was present in 47% of the patients; however, only two of the six patients with increased TR were paced. 3D TTE identified lead position in 92% of the cases-more than 50% of the cases showed RV lead distribution in the middle or post eroseptal commissure of the TV. Lead immobility was seen in only three of the six patients with increased TR.
CONCLUSIONS: These findings show that significant PPM-induced TR is uncommon immediately post-implantation and, when it occurs, causes no greater than mild TR. RV pacing and lead mobility do not correlate with worsening of TR. 3D TTE is highly reliable at identifying lead position.

Entities:  

Keywords:  Pacemaker; Post-implantation; Tricuspid regurgitation

Mesh:

Year:  2017        PMID: 28685199     DOI: 10.1007/s10840-017-0266-2

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  17 in total

1.  Transvenous pacemaker leads do not worsen tricuspid regurgitation: a prospective echocardiographic study.

Authors:  D W Leibowitz; S Rosenheck; A Pollak; M Geist; D Gilon
Journal:  Cardiology       Date:  2000       Impact factor: 1.869

2.  Right ventricular pacing increases tricuspid regurgitation grade regardless of the mechanical interference to the valve by the electrode.

Authors:  Mordehay Vaturi; Jairo Kusniec; Yaron Shapira; Roman Nevzorov; Idit Yedidya; Daniel Weisenberg; Daniel Monakier; Boris Strasberg; Alexander Sagie
Journal:  Eur J Echocardiogr       Date:  2010-02-25

Review 3.  Tricuspid Valve Dysfunction Following Pacemaker or Cardioverter-Defibrillator Implantation.

Authors:  James D Chang; Warren J Manning; Elisa Ebrille; Peter J Zimetbaum
Journal:  J Am Coll Cardiol       Date:  2017-05-09       Impact factor: 24.094

4.  3D echocardiographic location of implantable device leads and mechanism of associated tricuspid regurgitation.

Authors:  Anuj Mediratta; Karima Addetia; Megan Yamat; Joshua D Moss; Hemal M Nayak; Martin C Burke; Lynn Weinert; Francesco Maffessanti; Valluvan Jeevanandam; Victor Mor-Avi; Roberto M Lang
Journal:  JACC Cardiovasc Imaging       Date:  2014-03-13

5.  Atriogenic mitral valve reflux: diastolic mitral incompetence following isolated atrial systoles.

Authors:  J C Williams; P B O'Donovan; R A Vandenberg; R E Sturm; E H Wood
Journal:  Circ Res       Date:  1968-01       Impact factor: 17.367

6.  Tricuspid insufficiency does not increase early after permanent implantation of pacemaker leads.

Authors:  Nezihi Kucukarslan; Ata Kirilmaz; Eralp Ulusoy; Mehmet Yokusoglu; Nikola Gramatnikovski; Ertugrul Ozal; Harun Tatar
Journal:  J Card Surg       Date:  2006 Jul-Aug       Impact factor: 1.620

Review 7.  Tricuspid regurgitation in patients with pacemakers and implantable cardiac defibrillators: a comprehensive review.

Authors:  Rasha Al-Bawardy; Amar Krishnaswamy; Mandeep Bhargava; Justin Dunn; Oussama Wazni; E Murat Tuzcu; William Stewart; Samir R Kapadia
Journal:  Clin Cardiol       Date:  2013-03-25       Impact factor: 2.882

8.  Impact of tricuspid regurgitation on long-term survival.

Authors:  Jayant Nath; Elyse Foster; Paul A Heidenreich
Journal:  J Am Coll Cardiol       Date:  2004-02-04       Impact factor: 24.094

9.  The effect of transvenous pacemaker and implantable cardioverter defibrillator lead placement on tricuspid valve function: an observational study.

Authors:  Juyong B Kim; Daniel M Spevack; Paul A Tunick; John R Bullinga; Itzhak Kronzon; Larry A Chinitz; Harmony R Reynolds
Journal:  J Am Soc Echocardiogr       Date:  2007-07-02       Impact factor: 5.251

10.  Tricuspid incompetence following permanent pacemaker implantation.

Authors:  Marc Klutstein; Jonathan Balkin; Adi Butnaru; Michael Ilan; Amnon Lahad; David Rosenmann
Journal:  Pacing Clin Electrophysiol       Date:  2009-03       Impact factor: 1.976

View more
  3 in total

1.  Echocardiographic assessment of tricuspid regurgitation and pericardial effusion after cardiac device implantation.

Authors:  Katarzyna Wiechecka; Bartosz Wiechecki; Agnieszka Kapłon-Cieślicka; Agata Tymińska; Monika Budnik; Dominika Hołowaty; Krzysztof Jakubowski; Marcin Michalak; Elżbieta Świętoń; Przemysław Stolarz; Roman Steckiewicz; Marcin Grabowski; Piotr Scisło; Janusz Kochanowski; Krzysztof J Filipiak; Grzegorz Opolski
Journal:  Cardiol J       Date:  2019-06-21       Impact factor: 2.737

Review 2.  Endocardial transvenous pacing in patients with surgically palliated univentricular hearts: A review on different techniques, problems and management.

Authors:  Koneru Lakshmi Umamaheshwar; Arvind Sahadev Singh; Kothandam Sivakumar
Journal:  Indian Pacing Electrophysiol J       Date:  2018-11-30

3.  Real-time echocardiographic guidance for confirming septal placement of right ventricular leads: A pilot study.

Authors:  Manshu Yan; Tahmeed Contractor; Elyse Guran; Melissa McCabe; Uoo Kim
Journal:  J Arrhythm       Date:  2021-05-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.